Celgene Operating Income 2006-2019 | CELG

Celgene annual/quarterly operating income history and growth rate from 2006 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Celgene operating income for the quarter ending March 31, 2019 was $1.710B, a 684.4% increase year-over-year.
  • Celgene operating income for the twelve months ending March 31, 2019 was $6.683B, a 75.31% increase year-over-year.
  • Celgene annual operating income for 2018 was $5.191B, a 10.28% increase from 2017.
  • Celgene annual operating income for 2017 was $4.707B, a 48.67% increase from 2016.
  • Celgene annual operating income for 2016 was $3.166B, a 40.4% increase from 2015.
Celgene Annual Operating Income
(Millions of US $)
2018 $5,191
2017 $4,707
2016 $3,166
2015 $2,255
2014 $2,519
2013 $1,809
2012 $1,746
2011 $1,443
2010 $990
2009 $842
2008 $-1,464
2007 $425
2006 $175
2005 $84
Celgene Quarterly Operating Income
(Millions of US $)
Q1 2019 $1,710
Q4 2018 $1,807
Q3 2018 $1,680
Q2 2018 $1,486
Q1 2018 $218
Q4 2017 $1,198
Q3 2017 $1,085
Q2 2017 $1,311
Q1 2017 $1,113
Q4 2016 $929
Q3 2016 $412
Q2 2016 $823
Q1 2016 $1,002
Q4 2015 $901
Q3 2015 $80
Q2 2015 $416
Q1 2015 $859
Q4 2014 $752
Q3 2014 $647
Q2 2014 $759
Q1 2014 $362
Q4 2013 $326
Q3 2013 $456
Q2 2013 $564
Q1 2013 $464
Q4 2012 $321
Q3 2012 $502
Q2 2012 $441
Q1 2012 $482
Q4 2011 $405
Q3 2011 $431
Q2 2011 $319
Q1 2011 $288
Q4 2010 $241
Q3 2010 $311
Q2 2010 $168
Q1 2010 $270
Q4 2009 $283
Q3 2009 $236
Q2 2009 $160
Q1 2009 $162
Q4 2008 $-134
Q3 2008 $160
Q2 2008 $140
Q1 2008 $-1,629
Q4 2007 $137
Q3 2007 $88
Q2 2007 $115
Q1 2007 $84
Q4 2006 $60
Q3 2006 $54
Q2 2006 $30
Q1 2006 $30
Q4 2005 $15
Q3 2005 $10
Q2 2005 $37
Q1 2005 $22
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $67.169B $15.281B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $104.470B 11.81
Gilead Sciences (GILD) United States $85.278B 10.35
Illumina (ILMN) United States $45.930B 53.23
Biogen (BIIB) United States $44.025B 8.36
Vertex Pharmaceuticals (VRTX) United States $43.994B 53.18
Regeneron Pharmaceuticals (REGN) United States $34.155B 16.05
Alexion Pharmaceuticals (ALXN) United States $28.512B 16.14
Incyte (INCY) United States $17.530B 71.09
BioMarin Pharmaceutical (BMRN) United States $15.950B 0.00
Exact Sciences (EXAS) United States $12.511B 0.00
Seattle Genetics (SGEN) United States $11.153B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.999B 47.71
Sarepta Therapeutics (SRPT) United States $8.961B 0.00
QIAGEN (QGEN) Netherlands $8.614B 28.30
Bio-Techne Corp (TECH) United States $7.491B 51.11
Alnylam Pharmaceuticals (ALNY) United States $7.344B 0.00
Moderna (MRNA) United States $7.182B 0.00
Bluebird Bio (BLUE) United States $6.772B 0.00
Guardant Health (GH) United States $6.708B 0.00
Exelixis (EXEL) United States $6.144B 15.66
Galapagos (GLPG) Belgium $6.114B 0.00
Array BioPharma (ARRY) United States $6.007B 0.00
BeiGene (BGNE) Cayman Islands $5.905B 0.00
Amarin (AMRN) Ireland $5.693B 0.00
Ascendis Pharma (ASND) Denmark $5.434B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.420B 0.00
Spark Therapeutics (ONCE) United States $4.238B 0.00
Blueprint Medicines (BPMC) United States $4.137B 0.00
Alkermes (ALKS) Ireland $3.758B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.743B 0.00
China Biologic Products (CBPO) China $3.582B 22.75
Allogene Therapeutics (ALLO) United States $3.440B 0.00
Global Blood Therapeutics (GBT) United States $3.380B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.327B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.286B 0.00
Repligen (RGEN) United States $3.252B 81.01
Immunomedics (IMMU) United States $2.835B 0.00
Amicus Therapeutics (FOLD) United States $2.807B 0.00
Mirati Therapeutics (MRTX) United States $2.766B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.745B 0.00
Arena Pharmaceuticals (ARNA) United States $2.648B 5.38
Reata Pharmaceuticals (RETA) United States $2.632B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.616B 0.00
Medicines (MDCO) United States $2.578B 0.00
UniQure (QURE) Netherlands $2.381B 0.00
MyoKardia (MYOK) United States $2.295B 0.00
Halozyme Therapeutics (HALO) United States $2.242B 0.00
Ligand Pharmaceuticals (LGND) United States $2.230B 18.47
Emergent Biosolutions (EBS) United States $2.224B 19.32
Acceleron Pharma (XLRN) United States $2.216B 0.00
Lion Biotechnologies (IOVA) United States $2.131B 0.00
Insmed (INSM) United States $2.045B 0.00
NeoGenomics (NEO) United States $2.029B 132.81
AnaptysBio (ANAB) United States $2.019B 0.00
Genomic Health (GHDX) United States $2.005B 42.58
Denali Therapeutics (DNLI) United States $1.979B 0.00
Akcea Therapeutics (AKCA) United States $1.967B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.958B 0.00
Allakos (ALLK) United States $1.913B 0.00
Myriad Genetics (MYGN) United States $1.797B 17.88
Audentes Therapeutics (BOLD) United States $1.687B 0.00
REGENXBIO (RGNX) United States $1.672B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.659B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.598B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.529B 0.00
Innoviva (INVA) United States $1.469B 4.06
Coherus BioSciences (CHRS) United States $1.412B 0.00
Cambrex (CBM) United States $1.402B 17.73
Gossamer Bio (GOSS) United States $1.355B 0.00
Rubius Therapeutics (RUBY) United States $1.346B 0.00
Alector (ALEC) United States $1.343B 0.00
Aimmune Therapeutics (AIMT) United States $1.266B 0.00
Fate Therapeutics (FATE) United States $1.237B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.209B 0.00
Apellis Pharmaceuticals (APLS) United States $1.208B 0.00
Epizyme (EPZM) United States $1.174B 0.00
Sangamo Therapeutics (SGMO) United States $1.121B 0.00
Eidos Therapeutics (EIDX) United States $1.092B 0.00
Atara Biotherapeutics (ATRA) United States $1.075B 0.00
Editas Medicine (EDIT) United States $1.069B 0.00
Codexis (CDXS) United States $1.045B 0.00
RA PHARMCTL INC (RARX) United States $1.001B 0.00
NGM Biopharmaceuticals (NGM) United States $0.987B 0.00
Athenex (ATNX) United States $0.939B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.924B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.912B 0.00
InflaRx (IFRX) Germany $0.912B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.904B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.895B 0.00
Clovis Oncology (CLVS) United States $0.887B 0.00
Myovant Sciences (MYOV) United Kingdom $0.880B 0.00
WAVE Life Sciences (WVE) Singapore $0.871B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.862B 40.70
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.857B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.854B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.853B 0.00
G1 THERAPEUTICS (GTHX) United States $0.848B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.846B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.843B 0.00
ANI Pharmaceuticals (ANIP) United States $0.825B 14.63
Axsome Therapeutics (AXSM) United States $0.824B 0.00
MeiraGTx Holdings (MGTX) United States $0.812B 0.00
Retrophin (RTRX) United States $0.779B 0.00
Intra-Cellular Therapies (ITCI) United States $0.742B 0.00
Twist Bioscience (TWST) United States $0.729B 0.00
Principia Biopharma (PRNB) United States $0.721B 0.00
Cara Therapeutics (CARA) United States $0.718B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.715B 0.00
Cellectis (CLLS) France $0.715B 0.00
CORTEXYME INC (CRTX) United States $0.712B 0.00
Arvinas (ARVN) United States $0.710B 0.00
Vericel (VCEL) United States $0.692B 0.00
Precision BioSciences (DTIL) United States $0.691B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Intellia Therapeutics (NTLA) United States $0.679B 0.00
Zealand Pharma (ZEAL) Denmark $0.664B 7.76
Kura Oncology (KURA) United States $0.654B 0.00
Stemline Therapeutics (STML) United States $0.654B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.629B 0.00
Viking Therapeutics (VKTX) United States $0.615B 0.00
Puma Biotechnology (PBYI) United States $0.597B 0.00
Adverum Biotechnologies (ADVM) United States $0.585B 0.00
Cytokineticsorporated (CYTK) United States $0.580B 0.00
Heska (HSKA) United States $0.580B 59.37
ObsEva SA (OBSV) Switzerland $0.574B 0.00
Magenta Therapeutics (MGTA) United States $0.571B 0.00
Zymeworks (ZYME) Canada $0.566B 0.00
DBV Technologies (DBVT) France $0.550B 0.00
Anika Therapeutics (ANIK) United States $0.541B 18.49
Kaleido Biosciences (KLDO) $0.524B 0.00
Revance Therapeutics (RVNC) United States $0.511B 0.00
Scholar Rock Holding (SRRK) United States $0.510B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
CytomX Therapeutics (CTMX) United States $0.502B 0.00
Synthorx (THOR) United States $0.499B 0.00
MediciNova (MNOV) United States $0.494B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.489B 0.00
Acorda Therapeutics (ACOR) United States $0.489B 8.61
Mesoblast (MESO) Australia $0.478B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.477B 0.00
Replimune (REPL) United States $0.471B 0.00
MILESTONE PHARM (MIST) Canada $0.470B 0.00
Krystal Biotech (KRYS) United States $0.469B 0.00
NEXTCURE INC (NXTC) United States $0.437B 0.00
Sorrento Therapeutics (SRNE) United States $0.429B 0.00
Cyclerion Therapeutics (CYCN) United States $0.415B 0.00
Albireo Pharma (ALBO) United States $0.405B 0.00
Arcus Biosciences (RCUS) United States $0.399B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.394B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.384B 0.00
Agenus (AGEN) United States $0.384B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 0.00
Prothena (PRTA) Ireland $0.378B 0.00
AVROBIO (AVRO) United States $0.376B 0.00
Dynavax Technologies (DVAX) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.374B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
LogicBio Therapeutics (LOGC) United States $0.365B 0.00
UNITY Biotechnology (UBX) $0.363B 0.00
PDL BioPharma (PDLI) United States $0.357B 8.46
Biofrontera AG Sponsored ADR (BFRA) Germany $0.357B 0.00
Kodiak Sciences (KOD) United States $0.352B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.346B 0.00
AC Immune SA (ACIU) Switzerland $0.340B 21.87
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.340B 0.00
Senesco Technologies (ELOX) United States $0.340B 0.00
Kindred Biosciences (KIN) United States $0.332B 0.00
Five Prime Therapeutics (FPRX) United States $0.326B 0.00
AXCELLA HEALTH (AXLA) United States $0.326B 0.00
BeyondSpring (BYSI) United States $0.326B 0.00
XBiotech (XBIT) United States $0.325B 0.00
Kezar Life Sciences (KZR) United States $0.323B 0.00
Abeona Therapeutics (ABEO) United States $0.322B 0.00
Inovio Pharmaceuticals (INO) United States $0.320B 0.00
Cellular Biomedicine (CBMG) United States $0.309B 0.00
Merus (MRUS) Netherlands $0.299B 0.00
Geron (GERN) United States $0.289B 0.00
Kadmon Holdings (KDMN) United States $0.281B 0.00
ResTORbio (TORC) United States $0.273B 0.00
Constellation Pharmaceuticals (CNST) United States $0.272B 0.00
Athersys (ATHX) United States $0.270B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.260B 0.00
Protagonist Therapeutics (PTGX) United States $0.259B 0.00
PHASEBIO PHARMA (PHAS) United States $0.258B 0.00
Aduro Biotech (ADRO) United States $0.256B 0.00
ChromaDex (CDXC) United States $0.255B 0.00
Enochian BioSciences (ENOB) United States $0.250B 0.00
Evelo Biosciences (EVLO) United States $0.245B 0.00
Celcuity (CELC) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.238B 0.00
Mersana Therapeutics (MRSN) United States $0.236B 0.00
Urovant Sciences (UROV) United States $0.231B 0.00
Kamada (KMDA) Israel $0.229B 8.88
Syros Pharmaceuticals (SYRS) United States $0.222B 0.00
OvaScience (MLND) United States $0.221B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.220B 0.00
MannKind (MNKD) United States $0.220B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.217B 0.00
Arsanis (XFOR) United States $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.213B 0.00
Cerecor (CERC) United States $0.213B 0.00
Avid Bioservices (CDMO) United States $0.213B 0.00
Synlogic (SYBX) United States $0.208B 0.00
Chiasma (CHMA) United States $0.206B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.205B 0.00
Kala Pharmaceuticals (KALA) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
VBI Vaccines (VBIV) United States $0.199B 0.00
HOOKIPA PHARMA (HOOK) United States $0.198B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.197B 0.00
Solid Biosciences (SLDB) United States $0.195B 0.00
Celyad SA (CYAD) Belgium $0.193B 0.00
Affimed (AFMD) Germany $0.193B 0.00
Neothetics (EVFM) United States $0.191B 0.00
Liquidia Technologies (LQDA) United States $0.177B 0.00
Intec Pharma (NTEC) Israel $0.175B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.174B 0.00
Cue Biopharma (CUE) United States $0.173B 0.00
Compugen (CGEN) Israel $0.171B 0.00
APPLIED THERAPT (APLT) United States $0.171B 0.00
BioXcel Therapeutics (BTAI) United States $0.170B 0.00
XOMA (XOMA) United States $0.166B 0.00
Axovant Sciences (AXGT) United Kingdom $0.164B 0.00
Seres Therapeutics (MCRB) United States $0.163B 0.00
Anavex Life Sciences (AVXL) United States $0.162B 0.00
Menlo Therapeutics (MNLO) United States $0.161B 0.00
TREVI THERAPTCS (TRVI) United States $0.160B 0.00
Strongbridge Biopharma (SBBP) United States $0.159B 9.19
Checkpoint Therapeutics (CKPT) United States $0.157B 0.00
SESEN BIO, INC (SESN) United States $0.156B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Eton Pharmaceuticals (ETON) United States $0.147B 0.00
Novavax (NVAX) United States $0.144B 0.00
Provention Bio (PRVB) United States $0.142B 0.00
Mustang Bio (MBIO) United States $0.138B 0.00
OSMOTICA PHARM (OSMT) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.127B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.118B 0.00
Trevena (TRVN) United States $0.113B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Aptinyx (APTX) United States $0.112B 0.00
INmune Bio (INMB) United States $0.111B 0.00
TOCAGEN INC (TOCA) United States $0.109B 0.00
Dyadic (DYAI) United States $0.109B 0.00
Arbutus Biopharma (ABUS) Canada $0.109B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.108B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.107B 0.00
Equillium (EQ) United States $0.105B 0.00
Selecta Biosciences (SELB) United States $0.105B 0.00
NantKwest (NK) United States $0.105B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Unum Therapeutics (UMRX) United States $0.099B 0.00
Verastem (VSTM) United States $0.098B 0.00
Pluristem Therapeutics (PSTI) Israel $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Allena Pharmaceuticals (ALNA) United States $0.094B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.092B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Signal Genetics (MGEN) United States $0.086B 0.00
Cohbar (CWBR) United States $0.084B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.083B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.070B 0.00
Alcobra (ARCT) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
Sunesis Pharmaceuticals (SNSS) United States $0.068B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
ScPharmaceuticals (SCPH) United States $0.066B 0.00
OVID THERAPEUTC (OVID) United States $0.066B 0.00
Eyenovia (EYEN) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Apricus Biosciences (SEEL) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Ophthotech (ISEE) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.052B 0.00
AEterna Zentaris (AEZS) United States $0.052B 0.00
Cidara Therapeutics (CDTX) United States $0.051B 0.00
Hoth Therapeutics (HOTH) United States $0.050B 0.00
Moleculin Biotech (MBRX) United States $0.050B 0.00
Curis (CRIS) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.044B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.043B 0.00
Celsion (CLSN) United States $0.043B 0.00
VIVUS (VVUS) United States $0.041B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.040B 0.00
Oncolytics Biotech (ONCY) Canada $0.039B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Edge Therapeutics (PDSB) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.032B 0.00
Aytu Bioscience (AYTU) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
Motif Bio Plc (MTFB) United States $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
GENPREX INC (GNPX) United States $0.025B 0.00
Sophiris Bio (SPHS) United States $0.024B 0.00
GTx (GTXI) United States $0.024B 0.00
Adial Pharmaceuticals (ADIL) United States $0.023B 0.00
Bison Capital Acquisition (XYN) China $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Advaxis (ADXS) United States $0.016B 0.00
Histogenics (HSGX) United States $0.016B 0.00
OncoSec Medical (ONCS) United States $0.016B 0.00
Aileron Therapeutics (ALRN) United States $0.016B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Galena Biopharma (SLS) United States $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
IMMURON LTD (IMRN) Australia $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
RestorGenex (DFFN) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Vital Therapies (IMUX) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Alliqua BioMedical (ADYX) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.004B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00